Abstract:Familial Mediterranean Fever, a monogenic autoinflammatory disease secondary to MEFV gene mutations in the chromosome 16p13, is characterized by recurrent self-limiting attacks of fever, arthritis, aphthous changes in lips and/or oral mucosa, erythema, serositis. It is caused by dysregulation of the inflammasome, a complex intracellular multiprotein structure, commanding the overproduction of interleukin 1. Familial Mediterranean Fever can be associated with other multifactorial autoinflammatory diseases, as vasculitis and Behçet disease.Symptoms frequently start before 20 years of age and are characterized by a more severe phenotype in patients who begin earlier.Attacks consist of fever, serositis, arthritis and high levels of inflammatory reactants: C-reactive protein, erythrocyte sedimentation rate, serum amyloid A associated with leucocytosis and neutrophilia. The symptom-free intervals are of different length.The attacks of Familial Mediterranean Fever can have a trigger, as infections, stress, menses, exposure to cold, fat-rich food, drugs.The diagnosis needs a clinical definition of the disease and a genetic confirmation. An accurate differential diagnosis is mandatory to exclude infective agents, autoimmune diseases, etc.In many patients there is no genetic confirmation of the disease; furthermore, some subjects with the relieve of MEFV mutations, show a phenotype not in line with the diagnosis of Familial Mediterranean Fever. For these reasons, diagnostic criteria were developed, as Tel Hashomer Hospital criteria, the "Turkish FMF Paediatric criteria", the "clinical classification criteria for autoinflammatory periodic fevers" formulated by PRINTO.The goals of the treatment are: prevention of attacks recurrence, normalization of inflammatory markers, control of subclinical inflammation in attacks-free intervals and prevention of medium and long-term complications, as amyloidosis. Colchicine is the first step in the treatment; biological drugs are effective in non-responder patients.The goal of this paper is to give a wide and broad review to general paediatricians on Familial Mediterranean Fever, with the relative diagnostic, clinical and therapeutic aspects.

Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor

Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients

A plasmonic biosensor pre-diagnostic tool for Familial Mediterranean Fever

Genotypic Diagnosis of Familial Mediterranean Fever (FMF) Using New Microsatellite Markers: Example of Two Extensive Non-Ashkenazi Jewish Pedigrees.

A Novel Time-Resolved Fluoroimmunoassay Based on Magnetic Microspheres Method for Detecting Antibodies Against the Phospholipase A2 Receptor.

Exploring S100A8/A9, neopterin, and MMP3 in familial Mediterranean fever

Implementation of long-read sequencing for routine molecular diagnosis of familial mediterranean fever

Clinical Versus Genetic Diagnosis of Familial Mediterranean Fever.

Genewise detection of variants in MEFV gene using nanopore sequencing

Diagnostic delays in familial Mediterranean fever: a Juvenile Inflammatory Rheumatism (JIR) cohort study

Unraveling the genome: Familial Mediterranean fever

Pyrin Inflammasome Activation Defines Colchicine-Responsive SURF Patients from FMF and Other Recurrent Fevers

Histamine elevation in familial Mediterranean fever: A study from the Juvenile Inflammatory Rheumatism cohort

Experimental models in Familial Mediterranean Fever (FMF): Insights into pathophysiology and therapeutic strategies

FMF is not always "fever": from clinical presentation to "treat to target"

Molecular investigation of MEFV gene polymorphisms among patients with familial mediterranean fever-like symptoms

Epigenetic, transcriptional, and functional characterization of myeloid cells in Familial Mediterranean Fever

Granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-α in combination is a useful diagnostic biomarker to distinguish familial Mediterranean fever from sepsis

Complex regulation of alarmins S100A8/A9 and secretion via gasdermin D pores exacerbates autoinflammation in familial Mediterranean fever

Identification by Exome Sequencing of Predisposing Variants in Familial Cases of Autoinflammatory Recurrent Fevers

α9β1 integrin & its ligands as new potential biomarkers in FMF